Thursday, April 18, 2024 | Baltimore, MD
Baltimore, MD
Partly Cloudy

This MoCo biotech just raised another $20M to get its superbug-killing therapy through the clinic

April 5, 2022

Gaithersburg’s Adaptive Phage Therapeutics Inc. has raised another $20 million in funding, less than a year after securing nearly $41 million to advance its therapy for superbugs. The new funding brings the Series B total to $61 million, allowing the company to accelerate clinical trials for two programs: prosthetic joint infection and diabetic foot osteomyelitis, in which soft tissue infections can spread to the bone and require amputation.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.